Lipoxin A4 promotes reduction and antibiotic efficacy against Pseudomonas aeruginosa biofilm
Related Experiment Video
Updated: Dec 2, 2025

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
J M Thornton1, J M Walker1, P Y Kadiyam Sundarasivarao1
1Department of Cell Biology and Neuroscience, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA.
Abstract:
Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic bacterium commonly found in wound infections and airways of cystic fibrosis patients. P. aeruginosa readily forms biofilms which can reduce the efficacy of antibiotics used to eradicate the pathogen. We have previously shown that a Specialized Pro-resolving Mediator (SPM), Lipoxin A4 (LxA4) is a quorum sensing inhibitor which can reduce P. aeruginosa virulence. In this study, we examined the direct actions of LxA4 and RvD2 on P. aeruginosa biofilm formation and virulence gene expression. The influence of LxA4 on antibiotic efficacy and the combined effects on biofilm formation were also investigated. LxA4 and RvD2 reduced P. aeruginosa biofilm formation and virulence gene expression. LxA4 increased ciprofloxacin inhibition on biofilm formation but did not affect ciprofloxacin's action on non-adherent bacteria. On the other hand, LxA4 increased bacterial killing action of imipenem but did not affect imipenem's action on biofilm. We also found that LxA4 can increase ciprofloxacin's bacterial killing ability in established biofilm. Together these results suggest that LxA4 has direct effects on P. aeruginosa biofilm formation and can increase antibiotic efficacy directly.
Insights
Specialized Pro-resolving Mediators, Lipoxin A4 (LxA4) and RvD2, inhibit Pseudomonas aeruginosa biofilm formation and virulence. LxA4 also enhances antibiotic efficacy against established biofilms.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Pseudomonas aeruginosa (P. aeruginosa) forms biofilms, reducing antibiotic efficacy in infections.
- Lipoxin A4 (LxA4), a Specialized Pro-resolving Mediator (SPM), previously shown to inhibit P. aeruginosa virulence.
- Biofilm formation is a key factor in P. aeruginosa pathogenesis and treatment resistance.
Purpose of the Study:
- To investigate the direct effects of LxA4 and RvD2 on P. aeruginosa biofilm formation and virulence.
- To assess the impact of LxA4 on the efficacy of antibiotics against P. aeruginosa.
- To evaluate combined effects of LxA4 and antibiotics on biofilm.
Main Methods:
- Treatment of P. aeruginosa with LxA4 and RvD2.
- Measurement of biofilm formation and virulence gene expression.
- Assessment of antibiotic efficacy (ciprofloxacin, imipenem) alone and in combination with LxA4.
Main Results:
- LxA4 and RvD2 significantly reduced P. aeruginosa biofilm formation and virulence gene expression.
- LxA4 enhanced ciprofloxacin's inhibition of biofilm formation and imipenem's killing action.
- LxA4 improved ciprofloxacin's bacterial killing in established P. aeruginosa biofilms.
Conclusions:
- LxA4 and RvD2 directly inhibit P. aeruginosa biofilm formation and virulence.
- LxA4 enhances the efficacy of certain antibiotics against P. aeruginosa, including in established biofilms.
More Related Videos
07:47Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Biofilms
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Biological Methods for Microbial Control